NFKBIA Antibody
Mouse Monoclonal Antibody (Mab)
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application
| WB |
---|---|
Primary Accession | P25963 |
Reactivity | Human, Mouse |
Host | Mouse |
Clonality | Monoclonal |
Calculated MW | H=36;M=35 KDa |
Isotype | IgG1,κ |
Antigen Source | Human |
Gene ID | 4792 |
---|---|
Antigen Region | 53-240 aa |
Other Names | NFKBIA;IKBA; MAD3; NFKBI; NF-kappa-B inhibitor alpha; NF-kappa-B inhibitor alpha; I-kappa-B-alpha; NF-kappa-B inhibitor alpha; Major histocompatibility complex enhancer-binding protein MAD3 |
Dilution | WB~~1:1000 |
Target/Specificity | Purified His-tagged NFKBIA protein was used to produced this monoclonal antibody. |
Format | Purified monoclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein G column, followed by dialysis against PBS. |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Precautions | NFKBIA Antibody is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | NFKBIA |
---|---|
Synonyms | IKBA, MAD3, NFKBI |
Function | Inhibits the activity of dimeric NF-kappa-B/REL complexes by trapping REL (RELA/p65 and NFKB1/p50) dimers in the cytoplasm by masking their nuclear localization signals (PubMed:1493333, PubMed:36651806, PubMed:7479976). On cellular stimulation by immune and pro-inflammatory responses, becomes phosphorylated promoting ubiquitination and degradation, enabling the dimeric RELA to translocate to the nucleus and activate transcription (PubMed:7479976, PubMed:7628694, PubMed:7796813, PubMed:7878466). |
Cellular Location | Cytoplasm. Nucleus. Note=Shuttles between the nucleus and the cytoplasm by a nuclear localization signal (NLS) and a CRM1-dependent nuclear export. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Inhibits the activity of dimeric NF-kappa-B/REL complexes by trapping REL dimers in the cytoplasm through masking of their nuclear localization signals. On cellular stimulation by immune and proinflammatory responses, becomes phosphorylated promoting ubiquitination and degradation, enabling the dimeric RELA to translocate to the nucleus and activate transcription.
References
Huxford T., et al. Cell 95:759-770(1998).
Cockman M.E., et al. Proc. Natl. Acad. Sci. U.S.A. 103:14767-14772(2006).
Haskill S., et al. Cell 65:1281-1289(1991).
Jungnickel B., et al. J. Exp. Med. 191:395-402(2000).
Liu B., et al. Submitted (APR-2001) to the EMBL/GenBank/DDBJ databases.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.